bromocriptine has been researched along with Diabetes Mellitus in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (70.00) | 18.7374 |
1990's | 3 (10.00) | 18.2507 |
2000's | 3 (10.00) | 29.6817 |
2010's | 2 (6.67) | 24.3611 |
2020's | 1 (3.33) | 2.80 |
Authors | Studies |
---|---|
Bathla, M; Kalra, S; Verma, S | 1 |
Kopecky, C | 1 |
Banerjee, SK; Katare, PB | 1 |
Balsano, F; De Mattia, G; Fini, O; Laurenti, O | 1 |
Kesson, CM; Maccuish, AC; Ratcliffe, JG; Scobie, IN | 1 |
Althoff, PH; Fassbinder, W; Jungmann, E; Magnet, W; Rosak, C; Schöffling, K | 1 |
Molitvoslovova, NN | 1 |
Beastall, GH; Cohen, HN; Forbes, CD; Hay, ID; Lowe, GD; Middleton, SM; Prentice, CR; Singaraveloo, M; Thomson, JA | 1 |
Kowalik, E; Kwiatkowska, E; Paszko, Z; Tatoń, J | 1 |
Barnett, AH; Chapman, C; Gailer, K; Hayter, CJ | 1 |
Ieiri, T; Kasai, K; Naitoh, T; Nakamura, T; Shimoda, S; Shina, H; Suzuki, H; Takemura, Y | 1 |
Scriba, PC | 1 |
Jaedig, S | 1 |
Besser, GM; Bottazzo, GF; Cudworth, AG; Wass, JA; Woodrow, JC | 1 |
Aiba, T; Kovacs, K; Sano, T; Sawano, S; Shishiba, Y; Takada, K; Yamada, S | 1 |
Cincotta, AH; Phaneuf, S; Prevelige, R; Scislowski, PW; Tozzo, E; Zhang, Y | 1 |
Iwamoto, Y; Kawahara, R; Wasada, T | 1 |
Reaven, GM | 1 |
Cincotta, AH; DeFronzo, RA; Iozzo, P; Kumar, V; Lancaster, JL; Mahankali, A; Matsuda, M; Miyazaki, Y; Ohashi, S; Pijl, H; Pipek, R | 1 |
Steinbeck, K; Turtle, JR | 1 |
Chan, V; Wang, C; Yeung, RT | 1 |
Horrobin, DF | 1 |
Dirks, H; Köbberling, J; McIntosh, C; Schwinn, G | 1 |
Baba, S; Kobayashi, N; Morita, S; Oimomi, T; Terashi, K | 1 |
Makino, H; Nagasaka, A; Sakai, Y | 1 |
Kawano, N; Miyake, S; Nonaka, K; Shimizu, T; Watanabe, F | 1 |
Kanatsuka, A; Kumagai, A; Makino, H; Matsushima, Y; Yamamoto, M | 1 |
Dirks, H; Köbberling, J; Schwinn, G | 1 |
Atkinson, AB; Bell, PM; McCance, DR; McKnight, JA | 1 |
Djordjević, P; Djurić, DS; Micić, D; Mićić, J; Nesović, M; Popović, V | 1 |
4 review(s) available for bromocriptine and Diabetes Mellitus
Article | Year |
---|---|
Use of noninsulin antidiabetic medications in hospitalized patients.
Topics: Benzamides; Biguanides; Bromocriptine; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Glycoside Hydrolase Inhibitors; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Islet Amyloid Polypeptide; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2013 |
Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario.
Topics: Allopurinol; Aspirin; Bromocriptine; Cardiovascular Diseases; Clonidine; Colesevelam Hydrochloride; Diabetes Mellitus; Drug Discovery; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Metabolic Syndrome; Piperazines; Tadalafil | 2016 |
[Typical risks and avoidable errors in therapy: endocrinology and metabolism].
Topics: Body Weight; Bromocriptine; Diabetes Mellitus; Diet, Reducing; Endocrine System Diseases; Humans; Hypercalcemia; Hypoglycemia; Prolactin; Risk; Sella Turcica; Sulfonylurea Compounds; Thyroid Crisis; Vitamin D | 1982 |
Prolactin: role in health and disease.
Topics: Breast Neoplasms; Bromocriptine; Calcium; Diabetes Mellitus; Female; Humans; Infertility, Female; Lactation; Male; Mental Disorders; Neoplasms; Pregnancy; Premenstrual Syndrome; Prolactin; Sleep; Stress, Physiological; Time Factors; Water-Electrolyte Balance | 1979 |
2 trial(s) available for bromocriptine and Diabetes Mellitus
Article | Year |
---|---|
Effect of bromocriptine on maturity onset diabetes.
Topics: Blood Glucose; Bromocriptine; Diabetes Mellitus; Female; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Metoclopramide; Prolactin | 1980 |
Bromocriptine: a novel approach to the treatment of type 2 diabetes.
Topics: Abdomen; Adipose Tissue; Blood Glucose; Body Mass Index; Body Weight; Bromocriptine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Female; Glucose Tolerance Test; Glycated Hemoglobin; Hormone Antagonists; Humans; Hypoglycemic Agents; Male; Middle Aged; Obesity; Placebos; Time Factors; Viscera | 2000 |
24 other study(ies) available for bromocriptine and Diabetes Mellitus
Article | Year |
---|---|
Lemborexant: An adjuvant in difficult-to-control diabetes?
Topics: Adjuvants, Immunologic; Antipsychotic Agents; Bromocriptine; Diabetes Mellitus; Glucose; Humans; Orexin Receptor Antagonists; Sleep Initiation and Maintenance Disorders | 2022 |
[Effects of 2-bromo-alpha-ergocryptine in diabetic subjects].
Topics: Adult; Aged; Bromocriptine; Diabetes Mellitus; Female; Glucagon; Growth Hormone; Humans; Insulin; Male; Middle Aged | 1983 |
The effects of prolonged bromocriptine administration on PRL secretion GH and glycaemic control in stable insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; Bromocriptine; Depression, Chemical; Diabetes Mellitus; Growth Hormone; Humans; Insulin; Male; Prolactin; Time Factors | 1983 |
[Abnormal behavior of aldosterone in patients with diabetes mellitus].
Topics: Adult; Aldosterone; Bromocriptine; Diabetes Mellitus; Female; Furosemide; Humans; Male; Middle Aged | 1983 |
[Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
Topics: Acromegaly; Adult; Bromocriptine; C-Peptide; Carbohydrates; Diabetes Mellitus; Drug Evaluation; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin Antibodies; Male; Middle Aged; Pancreas | 1984 |
Effects of growth hormone, glucose and insulin on the factor VIII complex.
Topics: Antigens; Bromocriptine; Diabetes Mellitus; Factor VIII; Glucose; Glucose Tolerance Test; Glycoproteins; Growth Hormone; Humans; Insulin; von Willebrand Factor | 1982 |
[Prolactin secretion in patients with diabetes mellitus - TRH or bromocriptine function tests].
Topics: Adult; Bromocriptine; Diabetes Mellitus; Female; Hormones; Humans; Male; Pituitary Function Tests; Pituitary Gland, Anterior; Prolactin; Thyrotropin-Releasing Hormone | 1982 |
[Dopaminergic control of aldosterone secretion in man (author's transl)].
Topics: Adolescent; Adult; Aged; Aldosterone; Binding, Competitive; Bromocriptine; Diabetes Mellitus; Dopamine; Female; Humans; Hyperthyroidism; Male; Metoclopramide; Middle Aged; Receptors, Dopamine; Renin | 1980 |
[Medical treatment of acromegaly with bromocriptine].
Topics: Acromegaly; Bromocriptine; Diabetes Mellitus; Humans; Male; Middle Aged | 1982 |
An assessment of glucose intolerance in acromegaly and its response to medical treatment.
Topics: Acromegaly; Adult; Aged; Bromocriptine; Carbohydrate Metabolism; Diabetes Complications; Diabetes Mellitus; Female; Glucose Tolerance Test; HLA Antigens; Humans; Male; Middle Aged | 1980 |
Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
Topics: Adenoma; Adenoma, Chromophobe; Adult; Biomarkers, Tumor; Bromocriptine; Cytoplasmic Granules; Diabetes Mellitus; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hypertension; Keratins; Middle Aged; Neoplasm Proteins; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone; Treatment Outcome | 1993 |
Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adipose Tissue; Animals; Blood Glucose; Bromocriptine; Diabetes Mellitus; Dopamine Agonists; Drug Synergism; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Gluconeogenesis; Lipids; Lipolysis; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Weight Loss | 1999 |
Lack of evidence for bromocriptine effect on glucose tolerance, insulin resistance, and body fat stores in obese type 2 diabetic patients.
Topics: Abdomen; Adipose Tissue; Blood Glucose; Bromocriptine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dopamine Agonists; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Prolactin; Skin | 2000 |
Are the results really different?
Topics: Blood Glucose; Bromocriptine; Cholesterol, HDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dopamine Agonists; Female; Humans; Insulin Resistance; Obesity | 2000 |
Treatment of acromegaly with bromocryptine.
Topics: Acromegaly; Adolescent; Adult; Aged; Bromocriptine; Child; Child, Preschool; Diabetes Complications; Diabetes Mellitus; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Prolactin; Thyrotropin | 1979 |
Treatment of acromegaly with bromocriptine.
Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Diabetes Complications; Diabetes Mellitus; Female; Glucose Tolerance Test; Growth Hormone; Humans; Male; Middle Aged; Prolactin | 1979 |
Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months.
Topics: Acromegaly; Adult; Aged; Bromocriptine; Diabetes Mellitus; Ergolines; Female; Growth Hormone; Humans; Male; Middle Aged; Pimozide; Thyrotropin-Releasing Hormone | 1977 |
[Treatment with 2-bromo-alpha-ergocriptine (CB 154) in acromegaly associated with diabetes mellitus: especialy about improved glucose tolerance (author's transl)].
Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Diabetes Complications; Diabetes Mellitus; Glucose Tolerance Test; Humans; Male | 1979 |
[Effect of bromocriptine (CB-154) in diabetes associated with acromegaly].
Topics: Acromegaly; Bromocriptine; Diabetes Complications; Diabetes Mellitus; Growth Hormone; Humans; Male; Middle Aged | 1977 |
[Treatment with bromocriptine of acromegaly associated with diabetes; with special reference to ability of the drug to improve glucose metabolism disorder].
Topics: Acromegaly; Adult; Bromocriptine; Diabetes Mellitus; Female; Humans; Male; Middle Aged | 1977 |
[Effect of oral administration of 2-bromo-alpha-ergocriptine on blood glucose, serum IRI and HGH levels in normal subjects and diabetics (author's transl)].
Topics: Adult; Blood Glucose; Bromocriptine; Diabetes Mellitus; Female; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hypothalamus; Insulin; Male; Middle Aged; Radioimmunoassay; Receptors, Drug | 1977 |
[Therapy of acromegaly using bromocriptine].
Topics: Acromegaly; Administration, Oral; Blood Glucose; Bromocriptine; Diabetes Complications; Diabetes Mellitus; Ergolines; Female; Growth Hormone; Humans; Male; Sweating; Time Factors | 1975 |
Somatostatin analogue (SMS 201-995) in resistant acromegaly: a preliminary report.
Topics: Acromegaly; Adult; Bromocriptine; Diabetes Mellitus; Female; Growth Hormone; Humans; Male; Middle Aged; Octreotide; Pituitary Gland | 1990 |
Chronic bromocriptine treatment and glucose intolerance in acromegaly.
Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Middle Aged | 1985 |